Free Trial
→ While others chase AI stocks, smart traders do this (From WealthPress) (Ad) Buy MVIS Stock  Free MVIS Stock Alerts

MicroVision (MVIS) Financials

MicroVision logo
$1.31 +0.13 (+11.02%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$1.34 +0.03 (+2.67%)
As of 07:43 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for MicroVision

Annual Income Statements for MicroVision

This table shows MicroVision's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Income / (Loss) Attributable to Common Shareholders		 -97 -83 -53
Consolidated Net Income / (Loss)		 -97 -83 -53
Net Income / (Loss) Continuing Operations		 -97 -83 -53
Total Pre-Tax Income 		-96 -82 -53
Total Operating Income		 -86 -89 -54
Total Gross Profit		 -2.83 4.49 0.56
Total Revenue		 4.70 7.26 0.66
Operating Revenue		 4.70 7.26 0.66
Total Cost of Revenue		 7.53 2.77 0.10
Operating Cost of Revenue		 7.53 2.77 0.10
Total Operating Expenses		 83 93 54
Selling, General & Admin Expense		 29 37 24
Research & Development Expense		 49 57 30
Impairment Charge		 4.18 0.00 0.00
Other Special Charges / (Income)		 0.14 -0.03 0.00
Total Other Income / (Expense), net		 -11 7.18 0.80
Interest Expense		 4.46 0.08 0.06
Other Income / (Expense), net		 -6.43 7.26 0.86
Income Tax Expense		 0.51 1.15 0.00
Weighted Average Basic Shares Outstanding		 209.51M 182.80M 165.96M
Weighted Average Diluted Shares Outstanding		 209.51M 182.80M 165.96M
Weighted Average Basic & Diluted Shares Outstanding		 245.00M 195.27M 175.82M

Quarterly Income Statements for MicroVision

This table shows MicroVision's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 -31 -16 -24 -26 -20 -23 -21 -19 -13 -13
Consolidated Net Income / (Loss)		 -31 -16 -24 -26 -20 -23 -21 -19 -13 -13
Net Income / (Loss) Continuing Operations		 -31 -16 -24 -26 -20 -23 -21 -19 -13 -13
Total Pre-Tax Income 		-31 -15 -24 -26 -19 -23 -20 -19 -14 -13
Total Operating Income		 -18 -16 -25 -27 -20 -24 -24 -21 -14 -13
Total Gross Profit		 -2.47 -0.39 0.35 -0.32 4.20 0.42 -0.37 0.24 -0.03 -0.05
Total Revenue		 1.65 0.19 1.90 0.96 5.10 1.05 0.33 0.78 - 0.00
Operating Revenue		 1.65 0.19 1.90 0.96 5.10 1.05 0.33 0.78 - 0.00
Total Cost of Revenue		 4.12 0.58 1.55 1.28 0.90 0.63 0.70 0.54 0.03 0.05
Operating Cost of Revenue		 4.12 0.58 1.55 1.28 0.90 0.63 0.70 0.54 0.03 0.05
Total Operating Expenses		 16 15 25 26 24 24 24 21 14 13
Selling, General & Admin Expense		 5.92 6.60 7.75 9.08 9.52 8.74 9.69 8.74 6.38 5.52
Research & Development Expense		 8.76 8.74 14 17 15 16 14 13 7.59 7.54
Total Other Income / (Expense), net		 -13 0.30 0.79 0.63 0.63 0.64 3.57 2.35 0.48 0.25
Other Income / (Expense), net		 -8.15 0.30 0.79 0.63 0.71 0.64 3.57 2.35 - 0.25
Income Tax Expense		 0.08 0.11 0.08 0.23 0.48 0.21 0.28 0.18 - 0.00
Weighted Average Basic Shares Outstanding		 209.51M 213.00M 208.67M 196.75M 182.80M 188.31M 177.30M 174.70M 165.96M 165.69M
Weighted Average Diluted Shares Outstanding		 209.51M 213.00M 208.67M 196.75M 182.80M 188.31M 177.30M 174.70M 165.96M 165.69M
Weighted Average Basic & Diluted Shares Outstanding		 245.00M 219.02M 212.75M 206.66M 195.27M 189.99M 187.78M 176.52M 175.82M 166.04M

Annual Cash Flow Statements for MicroVision

This table details how cash moves in and out of MicroVision's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Change in Cash & Equivalents		 6.86 27 -62
Net Cash From Operating Activities		 -69 -67 -38
Net Cash From Continuing Operating Activities		 -69 -67 -38
Net Income / (Loss) Continuing Operations		 -97 -83 -53
Consolidated Net Income / (Loss)		 -97 -83 -53
Depreciation Expense		 6.92 7.86 2.25
Amortization Expense		 4.38 0.00 0.00
Non-Cash Adjustments To Reconcile Net Income		 26 13 16
Changes in Operating Assets and Liabilities, net		 -9.15 -5.36 -2.81
Net Cash From Investing Activities		 2.67 22 -38
Net Cash From Continuing Investing Activities		 2.67 22 -38
Purchase of Property, Plant & Equipment		 -0.37 -1.94 -4.36
Acquisitions		 -6.30 -11 -4.13
Purchase of Investments		 -26 -42 -90
Sale and/or Maturity of Investments		 35 77 61
Net Cash From Financing Activities		 73 72 14
Net Cash From Continuing Financing Activities		 73 72 14
Repayment of Debt		 0.00 0.00 -0.39
Issuance of Debt		 38 0.00 0.00
Issuance of Common Equity		 35 72 14
Other Financing Activities, net		 0.06 0.15 0.70
Effect of Exchange Rate Changes		 -0.17 0.27 0.00

Quarterly Cash Flow Statements for MicroVision

This table details how cash moves in and out of MicroVision's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 38 -10 -18 -3.05 -4.20 -13 39 5.46 -1.44 -15
Net Cash From Operating Activities		 -15 -14 -19 -21 -17 -20 -17 -13 -8.40 -9.01
Net Cash From Continuing Operating Activities		 -15 -14 -19 -21 -17 -20 -17 -13 -8.40 -9.00
Net Income / (Loss) Continuing Operations		 -31 -16 -24 -26 -20 -23 -21 -19 -13 -13
Consolidated Net Income / (Loss)		 -31 -16 -24 -26 -20 -23 -21 -19 -13 -13
Depreciation Expense		 1.67 1.68 1.77 1.80 1.58 2.14 1.63 2.52 0.82 0.52
Non-Cash Adjustments To Reconcile Net Income		 14 2.26 6.55 3.48 4.39 4.40 3.78 0.68 3.29 4.15
Changes in Operating Assets and Liabilities, net		 -3.90 -2.51 -3.03 0.28 -2.81 -3.45 -1.44 2.34 0.96 -0.82
Net Cash From Investing Activities		 6.50 3.58 -4.13 -3.28 0.44 2.70 12 6.25 -7.03 -6.28
Net Cash From Continuing Investing Activities		 6.50 3.58 -4.13 -3.28 0.44 2.70 12 6.25 -7.03 -6.28
Purchase of Property, Plant & Equipment		 -0.10 0.01 -0.17 -0.11 0.05 -0.50 -0.87 -0.62 -2.34 -0.89
Purchase of Investments		 -0.50 -2.08 -16 -7.81 -15 -9.80 -13 -3.90 -26 -26
Sale and/or Maturity of Investments		 7.10 5.66 15 7.90 15 13 27 22 26 20
Net Cash From Financing Activities		 47 -0.02 5.15 21 12 4.74 43 13 14 0.31
Net Cash From Continuing Financing Activities		 47 -0.02 5.15 21 12 4.74 43 13 14 0.31
Issuance of Common Equity		 8.66 -0.02 5.15 21 12 4.74 43 13 14 -
Effect of Exchange Rate Changes		 -0.30 0.11 0.06 -0.03 0.27 - - 0.00 - -

Annual Balance Sheets for MicroVision

This table presents MicroVision's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Total Assets		 121 130 115
Total Current Assets		 82 87 91
Cash & Equivalents		 54 45 21
Restricted Cash		 0.26 3.26 0.00
Short-Term Investments		 20 29 62
Accounts Receivable		 0.93 0.95 0.00
Inventories, net		 2.29 3.87 1.86
Other Current Assets		 4.29 4.89 6.44
Plant, Property, & Equipment, net		 7.06 9.03 6.83
Total Noncurrent Assets		 32 34 17
Intangible Assets		 11 17 0.08
Other Noncurrent Operating Assets		 21 17 17
Total Liabilities & Shareholders' Equity		 121 130 115
Total Liabilities		 72 34 25
Total Current Liabilities		 46 21 11
Short-Term Debt		 24 0.00 0.00
Accounts Payable		 1.13 2.27 2.06
Accrued Expenses		 2.54 15 2.06
Other Current Liabilities		 18 3.29 2.71
Total Noncurrent Liabilities		 26 13 14
Long-Term Debt		 8.75 0.00 -
Capital Lease Obligations		 16 13 -
Other Noncurrent Operating Liabilities		 1.73 0.61 14
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 49 96 90
Total Preferred & Common Equity		 49 96 90
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 49 96 90
Common Stock		 911 861 772
Retained Earnings		 -862 -765 -683
Accumulated Other Comprehensive Income / (Loss)		 0.00 0.21 -0.13

Quarterly Balance Sheets for MicroVision

This table presents MicroVision's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 88 103 124 136 149 123 109
Total Current Assets		 53 67 82 91 103 77 88
Cash & Equivalents		 17 27 44 49 62 23 22
Restricted Cash		 0.27 0.07 0.07 3.26 3.26 3.26 -
Short-Term Investments		 27 30 29 29 32 45 61
Accounts Receivable		 0.23 1.97 1.12 0.74 0.82 0.51 -
Inventories, net		 4.49 4.20 3.74 3.62 2.93 3.12 1.76
Other Current Assets		 4.86 3.65 4.30 5.77 2.33 2.37 2.83
Plant, Property, & Equipment, net		 7.67 8.13 8.55 9.46 9.95 10 4.55
Total Noncurrent Assets		 28 29 33 35 35 36 17
Intangible Assets		 13 13 17 18 18 19 0.09
Other Noncurrent Operating Assets		 15 16 17 17 17 17 17
Total Liabilities & Shareholders' Equity		 88 103 124 136 149 123 109
Total Liabilities		 22 25 30 38 36 37 24
Total Current Liabilities		 11 13 18 24 23 22 9.96
Short-Term Debt		 0.00 0.00 5.14 8.55 8.48 - 0.00
Accounts Payable		 1.49 1.45 2.16 2.29 1.89 3.63 1.52
Accrued Expenses		 5.89 8.89 9.97 7.20 6.60 10 1.59
Current Deferred Revenue		 0.18 0.17 0.21 4.96 5.73 - 4.60
Other Current Liabilities		 3.05 2.14 0.27 1.06 0.00 8.11 2.25
Total Noncurrent Liabilities		 12 12 13 14 13 15 14
Other Noncurrent Operating Liabilities		 12 12 13 14 13 14 14
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 66 79 94 98 113 87 86
Total Preferred & Common Equity		 66 79 94 98 113 87 86
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 66 79 94 98 113 87 86
Common Stock		 897 894 885 844 835 788 755
Retained Earnings		 -831 -816 -792 -746 -722 -702 -669
Accumulated Other Comprehensive Income / (Loss)		 0.34 0.10 0.16 0.05 -0.01 0.06 -0.19

Annual Metrics And Ratios for MicroVision

This table displays calculated financial ratios and metrics derived from MicroVision's official financial filings.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Growth Metrics		 - - -
Revenue Growth		 -35.31% 993.22% -73.44%
EBITDA Growth		 -9.35% -45.23% -19.69%
EBIT Growth		 -12.66% -53.91% -20.82%
NOPAT Growth		 3.78% -64.92% -22.84%
Net Income Growth		 -16.99% -56.04% -22.90%
EPS Growth		 0.00% -40.63% -18.52%
Operating Cash Flow Growth		 -2.16% -76.46% -29.30%
Free Cash Flow Firm Growth		 40.98% -84.57% -35.15%
Invested Capital Growth		 -27.69% 347.63% 420.36%
Revenue Q/Q Growth		 -42.36% 236.38% -45.62%
EBITDA Q/Q Growth		 -3.70% 2.79% -0.23%
EBIT Q/Q Growth		 -8.69% 1.65% -0.98%
NOPAT Q/Q Growth		 1.63% -7.10% -2.62%
Net Income Q/Q Growth		 -13.35% -8.18% -1.63%
EPS Q/Q Growth		 0.00% -4.65% 0.00%
Operating Cash Flow Q/Q Growth		 2.17% -13.88% -0.65%
Free Cash Flow Firm Q/Q Growth		 11.41% -6.69% -13.94%
Invested Capital Q/Q Growth		 1.69% 23.42% 196.83%
Profitability Metrics		 - - -
Gross Margin		 -60.35% 61.81% 84.94%
EBITDA Margin		 -1,717.40% -1,016.01% -7,648.04%
Operating Margin		 -1,821.10% -1,224.34% -8,115.96%
EBIT Margin		 -1,958.07% -1,124.34% -7,986.30%
Profit (Net Income) Margin		 -2,063.78% -1,141.23% -7,995.63%
Tax Burden Percent		 100.53% 101.40% 100.00%
Interest Burden Percent		 104.85% 100.10% 100.12%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -220.74% -323.11% -1,559.77%
ROIC Less NNEP Spread (ROIC-NNEP)		 -138.71% -295.05% -1,544.22%
Return on Net Nonoperating Assets (RNNOA)		 86.67% 233.81% 1,507.33%
Return on Equity (ROE)		 -134.07% -89.30% -52.44%
Cash Return on Invested Capital (CROIC)		 -188.60% -450.06% -667.66%
Operating Return on Assets (OROA)		 -73.33% -66.73% -43.25%
Return on Assets (ROA)		 -77.29% -67.73% -43.30%
Return on Common Equity (ROCE)		 -134.07% -89.30% -52.44%
Return on Equity Simple (ROE_SIMPLE)		 -198.72% -86.47% -59.16%
Net Operating Profit after Tax (NOPAT)		 -60 -62 -38
NOPAT Margin		 -1,274.77% -857.04% -5,681.17%
Net Nonoperating Expense Percent (NNEP)		 -82.03% -28.06% -15.55%
Return On Investment Capital (ROIC_SIMPLE)		 -61.26% -57.33% -42.04%
Cost of Revenue to Revenue		 160.35% 38.19% 15.06%
SG&A Expenses to Revenue		 624.91% 505.43% 3,620.63%
R&D to Revenue		 1,043.76% 781.20% 4,580.27%
Operating Expenses to Revenue		 1,760.75% 1,286.16% 8,200.90%
Earnings before Interest and Taxes (EBIT)		 -92 -82 -53
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -81 -74 -51
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 5.88 5.28 4.35
Price to Tangible Book Value (P/TBV)		 7.59 6.43 4.35
Price to Revenue (P/Rev)		 61.10 69.62 587.62
Price to Earnings (P/E)		 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 11.46 14.01 43.73
Enterprise Value to Revenue (EV/Rev)		 55.56 60.76 463.06
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 1.00 0.13 0.00
Long-Term Debt to Equity		 0.51 0.13 0.00
Financial Leverage		 -0.62 -0.79 -0.98
Leverage Ratio		 1.73 1.32 1.21
Compound Leverage Factor		 1.82 1.32 1.21
Debt to Total Capital		 50.10% 11.72% 0.00%
Short-Term Debt to Total Capital		 24.81% 0.00% 0.00%
Long-Term Debt to Total Capital		 25.28% 11.72% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 49.90% 88.28% 100.00%
Debt to EBITDA		 -0.61 -0.17 0.00
Net Debt to EBITDA		 0.32 0.87 0.00
Long-Term Debt to EBITDA		 -0.31 -0.17 0.00
Debt to NOPAT		 -0.82 -0.20 0.00
Net Debt to NOPAT		 0.43 1.03 0.00
Long-Term Debt to NOPAT		 -0.41 -0.20 0.00
Altman Z-Score		 -9.69 -0.71 0.28
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 1.79 4.23 7.97
Quick Ratio		 1.65 3.64 7.24
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 -51 -87 -47
Operating Cash Flow to CapEx		 -18,326.20% -3,467.18% -872.20%
Free Cash Flow to Firm to Interest Expense		 -11.48 -1,083.22 -757.26
Operating Cash Flow to Interest Expense		 -15.38 -838.63 -613.21
Operating Cash Flow Less CapEx to Interest Expense		 -15.46 -862.81 -683.52
Efficiency Ratios		 - - -
Asset Turnover		 0.04 0.06 0.01
Accounts Receivable Turnover		 5.01 0.00 0.00
Inventory Turnover		 2.44 0.97 0.05
Fixed Asset Turnover		 0.58 0.92 0.13
Accounts Payable Turnover		 4.43 1.28 0.04
Days Sales Outstanding (DSO)		 72.87 0.00 0.00
Days Inventory Outstanding (DIO)		 149.49 377.57 6,644.83
Days Payable Outstanding (DPO)		 82.48 285.21 10,302.13
Cash Conversion Cycle (CCC)		 139.88 92.37 -3,657.30
Capital & Investment Metrics		 - - -
Invested Capital		 23 31 7.03
Invested Capital Turnover		 0.17 0.38 0.27
Increase / (Decrease) in Invested Capital		 -8.72 24 9.23
Enterprise Value (EV)		 261 441 307
Market Capitalization		 287 505 390
Book Value per Share		 $0.22 $0.50 $0.54
Tangible Book Value per Share		 $0.17 $0.41 $0.54
Total Capital		 98 109 90
Total Debt		 49 13 0.00
Total Long-Term Debt		 25 13 0.00
Net Debt		 -26 -64 -83
Capital Expenditures (CapEx)		 0.37 1.94 4.36
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -14 -11 -3.13
Debt-free Net Working Capital (DFNWC)		 61 66 80
Net Working Capital (NWC)		 37 66 80
Net Nonoperating Expense (NNE)		 37 21 15
Net Nonoperating Obligations (NNO)		 -26 -64 -83
Total Depreciation and Amortization (D&A)		 11 7.86 2.25
Debt-free, Cash-free Net Working Capital to Revenue		 -302.30% -148.64% -470.93%
Debt-free Net Working Capital to Revenue		 1,294.02% 912.67% 11,985.24%
Net Working Capital to Revenue		 777.66% 912.67% 11,985.24%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.45) ($0.32)
Adjusted Weighted Average Basic Shares Outstanding		 209.51M 182.80M 165.96M
Adjusted Diluted Earnings per Share		 $0.00 ($0.45) ($0.32)
Adjusted Weighted Average Diluted Shares Outstanding		 209.51M 182.80M 165.96M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 245.00M 195.27M 175.82M
Normalized Net Operating Profit after Tax (NOPAT)		 -57 -62 -38
Normalized NOPAT Margin		 -1,210.32% -857.37% -5,681.17%
Pre Tax Income Margin		 -2,052.98% -1,125.44% -7,995.63%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 -20.63 -1,020.20 -855.31
NOPAT to Interest Expense		 -13.43 -777.66 -608.44
EBIT Less CapEx to Interest Expense		 -20.71 -1,044.39 -925.61
NOPAT Less CapEx to Interest Expense		 -13.52 -801.84 -678.74
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for MicroVision

This table displays calculated financial ratios and metrics derived from MicroVision's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 -67.65% -81.85% 477.51% 22.25% 0.00% 0.00% 4.78% 123.43% 0.00% -100.00%
EBITDA Growth		 -41.67% 34.98% -18.03% -48.75% -33.64% -71.34% -41.92% -29.12% -8.01% -27.16%
EBIT Growth		 -38.76% 33.75% -17.29% -38.38% -37.06% -80.98% -49.52% -43.60% -10.89% -27.63%
NOPAT Growth		 7.12% 34.27% -3.06% -26.04% -42.12% -82.38% -74.85% -61.47% -10.89% -30.12%
Net Income Growth		 -57.85% 33.88% -16.11% -38.29% -46.47% -82.62% -51.57% -44.49% -6.73% -36.98%
EPS Growth		 0.00% 41.67% 8.33% -18.18% -25.00% -50.00% -50.00% -37.50% 0.00% 0.00%
Operating Cash Flow Growth		 9.18% 30.89% -11.97% -53.98% -97.29% -126.23% -71.62% -23.61% -2.99% 9.59%
Free Cash Flow Firm Growth		 89.01% 80.25% 60.40% 3.68% -101.68% -192.75% -139.47% -91.53% -47.85% -4.35%
Invested Capital Growth		 -27.69% -12.24% -7.96% 65.98% 347.63% 976.57% 1,195.65% 4,772.73% 420.36% 214.11%
Revenue Q/Q Growth		 768.42% -90.00% 98.74% -81.26% 387.20% 218.24% -57.93% 0.00% 0.00% -100.00%
EBITDA Q/Q Growth		 -81.63% 37.79% 9.07% -37.28% 16.64% -12.93% -14.59% -23.90% -6.87% 6.46%
EBIT Q/Q Growth		 -72.74% 35.38% 8.56% -35.39% 17.53% -14.40% -7.87% -34.66% -8.90% 5.49%
NOPAT Q/Q Growth		 -17.61% 36.23% 7.78% -34.30% 16.77% 0.02% -12.78% -51.42% -6.82% 4.15%
Net Income Q/Q Growth		 -100.78% 35.16% 9.06% -33.32% 15.90% -13.88% -8.31% -41.20% -4.86% 5.49%
EPS Q/Q Growth		 0.00% 36.36% 15.38% -30.00% 16.67% 0.00% -9.09% -37.50% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 -6.85% 24.38% 10.24% -25.22% 18.69% -22.51% -23.44% -60.44% 6.76% 7.06%
Free Cash Flow Firm Q/Q Growth		 46.46% 48.68% 47.01% 9.39% 3.75% -2.89% -28.89% -58.01% -39.71% 15.84%
Invested Capital Q/Q Growth		 1.69% 1.95% -14.91% 2.94% 23.42% 6.92% 53.45% 121.05% 196.83% 28.68%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 -149.45% -206.84% 18.21% -33.58% 82.32% 40.31% -113.07% 30.43% 0.00% 0.00%
EBITDA Margin		 -1,511.70% -7,227.89% -1,161.89% -2,539.64% -345.15% -2,017.29% -5,684.80% -2,087.21% 0.00% 0.00%
Operating Margin		 -1,119.52% -8,266.32% -1,296.37% -2,793.93% -389.90% -2,282.24% -7,264.44% -2,709.85% 0.00% 0.00%
EBIT Margin		 -1,613.15% -8,110.00% -1,255.05% -2,727.93% -376.04% -2,221.39% -6,179.33% -2,409.97% 0.00% 0.00%
Profit (Net Income) Margin		 -1,888.18% -8,166.84% -1,259.47% -2,752.41% -386.92% -2,241.55% -6,264.13% -2,433.12% 0.00% 0.00%
Tax Burden Percent		 100.26% 100.70% 100.35% 100.90% 102.47% 100.91% 101.37% 100.96% 99.67% 100.00%
Interest Burden Percent		 116.74% 100.00% 100.00% 100.00% 100.42% 100.00% 100.00% 100.00% 96.60% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -135.70% -1,968.88% -356.75% -703.23% -102.90% -247.38% -439.76% -262.12% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -95.35% -1,961.10% -347.55% -692.27% -94.99% -238.73% -435.47% -257.30% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 59.58% 1,388.87% 264.29% 533.56% 75.27% 202.54% 381.31% 235.82% 0.00% 0.00%
Return on Equity (ROE)		 -76.12% -580.02% -92.46% -169.66% -27.62% -44.83% -58.44% -26.30% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 -188.60% -241.13% -282.44% -369.25% -450.06% -582.80% -564.67% -738.76% -667.66% -1,739.39%
Operating Return on Assets (OROA)		 -60.41% -589.38% -89.66% -163.89% -22.32% -39.08% -53.67% -21.92% 0.00% 0.00%
Return on Assets (ROA)		 -70.71% -593.51% -89.98% -165.36% -22.96% -39.43% -54.40% -22.13% 0.00% 0.00%
Return on Common Equity (ROCE)		 -76.12% -580.02% -92.46% -169.66% -27.62% -44.83% -58.44% -26.30% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -129.83% -118.73% -96.08% 0.00% -77.94% -58.63% -68.12% 0.00% -61.01%
Net Operating Profit after Tax (NOPAT)		 -13 -11 -17 -19 -14 -17 -17 -15 -9.80 -9.17
NOPAT Margin		 -783.66% -5,786.42% -907.46% -1,955.75% -272.93% -1,597.56% -5,085.11% -1,896.89% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -40.35% -7.78% -9.20% -10.96% -7.91% -8.64% -4.29% -4.82% -3.72% -3.54%
Return On Investment Capital (ROIC_SIMPLE)		 -13.23% - - - -12.83% - - - -10.92% -
Cost of Revenue to Revenue		 249.45% 306.84% 81.79% 133.58% 17.68% 59.69% 213.07% 69.57% 0.00% 0.00%
SG&A Expenses to Revenue		 358.97% 3,473.16% 407.68% 949.58% 186.57% 835.05% 2,945.90% 1,117.26% 0.00% 0.00%
R&D to Revenue		 531.15% 4,597.89% 747.58% 1,810.77% 285.83% 1,488.44% 4,210.03% 1,623.02% 0.00% 0.00%
Operating Expenses to Revenue		 970.06% 8,059.47% 1,314.58% 2,760.36% 472.22% 2,322.54% 7,151.37% 2,740.28% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -27 -15 -24 -26 -19 -23 -20 -19 -14 -13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -25 -14 -22 -24 -18 -21 -19 -16 -13 -12
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 5.88 3.68 2.78 3.83 5.28 4.19 7.19 5.42 4.35 6.98
Price to Tangible Book Value (P/TBV)		 7.59 4.55 3.34 4.66 6.43 5.11 8.58 6.95 4.35 6.99
Price to Revenue (P/Rev)		 61.10 29.77 24.33 48.34 69.62 190.57 727.69 428.32 587.62 489.40
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 11.46 8.89 7.39 11.29 14.01 13.27 30.18 25.63 43.73 217.10
Enterprise Value to Revenue (EV/Rev)		 55.56 24.43 18.03 39.19 60.76 156.85 647.90 363.54 463.06 421.21
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 1.00 0.00 0.00 0.05 0.13 0.09 0.08 0.00 0.00 0.00
Long-Term Debt to Equity		 0.51 0.00 0.00 0.00 0.13 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.62 -0.71 -0.76 -0.77 -0.79 -0.85 -0.88 -0.92 -0.98 -1.00
Leverage Ratio		 1.73 1.37 1.32 1.37 1.32 1.33 1.24 1.27 1.21 1.17
Compound Leverage Factor		 2.03 1.37 1.32 1.37 1.32 1.33 1.24 1.27 1.17 1.17
Debt to Total Capital		 50.10% 0.00% 0.00% 5.19% 11.72% 8.01% 7.01% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 24.81% 0.00% 0.00% 5.19% 0.00% 8.01% 7.01% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 25.28% 0.00% 0.00% 0.00% 11.72% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 49.90% 100.00% 100.00% 94.81% 88.28% 91.99% 92.99% 100.00% 100.00% 100.00%
Debt to EBITDA		 -0.61 0.00 0.00 -0.06 -0.17 -0.11 -0.13 0.00 0.00 0.00
Net Debt to EBITDA		 0.32 0.00 0.00 0.83 0.87 0.96 1.33 0.00 0.00 1.64
Long-Term Debt to EBITDA		 -0.31 0.00 0.00 0.00 -0.17 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 -0.82 0.00 0.00 -0.08 -0.20 -0.15 -0.17 0.00 0.00 0.00
Net Debt to NOPAT		 0.43 0.00 0.00 1.03 1.03 1.25 1.75 0.00 0.00 2.26
Long-Term Debt to NOPAT		 -0.41 0.00 0.00 0.00 -0.20 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -7.91 -6.60 -5.77 -1.84 0.88 -1.09 6.82 -0.26 1.40 7.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 1.79 5.00 5.26 4.64 4.23 3.80 4.55 3.48 7.97 8.82
Quick Ratio		 1.65 4.09 4.64 4.18 3.64 3.27 4.17 3.08 7.24 8.36
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -4.22 -7.87 -15 -29 -38 -40 -39 -30 -19 -14
Operating Cash Flow to CapEx		 -14,617.48% 0.00% -11,225.30% -18,209.65% 0.00% -4,102.21% -1,915.07% -2,192.20% -358.80% -1,013.72%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.04 0.07 0.07 0.06 0.06 0.02 0.01 0.01 0.01 0.01
Accounts Receivable Turnover		 5.01 16.76 6.45 9.14 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 2.44 1.07 1.22 1.02 0.97 0.71 0.56 0.26 0.05 0.08
Fixed Asset Turnover		 0.58 0.95 1.00 0.79 0.92 0.31 0.17 0.16 0.13 0.33
Accounts Payable Turnover		 4.43 2.28 2.61 1.21 1.28 1.00 0.80 0.23 0.04 0.08
Days Sales Outstanding (DSO)		 72.87 21.77 56.57 39.95 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 149.49 342.59 298.83 356.88 377.57 515.76 657.44 1,406.11 6,644.83 4,672.00
Days Payable Outstanding (DPO)		 82.48 159.88 139.79 301.48 285.21 365.67 455.91 1,582.05 10,302.13 4,622.80
Cash Conversion Cycle (CCC)		 139.88 204.49 215.62 95.35 92.37 150.09 201.54 -175.94 -3,657.30 49.20
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 23 22 22 26 31 26 24 16 7.03 2.37
Invested Capital Turnover		 0.17 0.34 0.39 0.36 0.38 0.15 0.09 0.14 0.27 8.33
Increase / (Decrease) in Invested Capital		 -8.72 -3.12 -1.90 10 24 23 22 15 9.23 4.45
Enterprise Value (EV)		 261 199 162 291 441 338 720 398 307 514
Market Capitalization		 287 243 219 359 505 411 808 469 390 598
Book Value per Share		 $0.22 $0.31 $0.38 $0.48 $0.50 $0.52 $0.64 $0.49 $0.54 $0.52
Tangible Book Value per Share		 $0.17 $0.25 $0.32 $0.40 $0.41 $0.43 $0.53 $0.38 $0.54 $0.52
Total Capital		 98 66 79 99 109 107 121 87 90 86
Total Debt		 49 0.00 0.00 5.14 13 8.55 8.48 0.00 0.00 0.00
Total Long-Term Debt		 25 0.00 0.00 0.00 13 0.00 0.00 0.00 0.00 0.00
Net Debt		 -26 -43 -57 -68 -64 -73 -89 -71 -83 -83
Capital Expenditures (CapEx)		 0.10 -0.01 0.17 0.11 -0.05 0.50 0.87 0.62 2.34 0.89
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -14 -1.04 -2.83 -3.45 -11 -5.39 -8.08 -16 -3.13 -5.37
Debt-free Net Working Capital (DFNWC)		 61 42 54 70 66 76 89 55 80 78
Net Working Capital (NWC)		 37 42 54 65 66 67 81 55 80 78
Net Nonoperating Expense (NNE)		 18 4.52 6.69 7.62 5.81 6.74 3.88 4.19 3.68 3.68
Net Nonoperating Obligations (NNO)		 -26 -43 -57 -68 -64 -73 -89 -71 -83 -83
Total Depreciation and Amortization (D&A)		 1.67 1.68 1.77 1.80 1.58 2.14 1.63 2.52 0.82 0.52
Debt-free, Cash-free Net Working Capital to Revenue		 -302.30% -12.72% -31.45% -46.47% -148.64% -249.91% -726.82% -1,474.36% -470.93% -439.56%
Debt-free Net Working Capital to Revenue		 1,294.02% 520.88% 598.88% 937.51% 912.67% 3,517.75% 8,016.29% 5,003.19% 11,985.24% 6,379.28%
Net Working Capital to Revenue		 777.66% 520.88% 598.88% 868.41% 912.67% 3,121.46% 7,252.66% 5,003.19% 11,985.24% 6,379.28%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.07) ($0.11) ($0.13) ($0.10) ($0.12) ($0.12) ($0.11) ($0.08) $0.00
Adjusted Weighted Average Basic Shares Outstanding		 209.51M 213.00M 208.67M 196.75M 182.80M 188.31M 177.30M 174.70M 165.96M 166.04M
Adjusted Diluted Earnings per Share		 $0.00 ($0.07) ($0.11) ($0.13) ($0.10) ($0.12) ($0.12) ($0.11) ($0.08) $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 209.51M 213.00M 208.67M 196.75M 182.80M 188.31M 177.30M 174.70M 165.96M 166.04M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 245.00M 219.02M 212.75M 206.66M 195.27M 189.99M 187.78M 176.52M 175.82M 166.04M
Normalized Net Operating Profit after Tax (NOPAT)		 -13 -11 -15 -19 -14 -17 -17 -15 -9.80 -9.17
Normalized NOPAT Margin		 -783.66% -5,794.53% -795.94% -1,955.75% -272.93% -1,598.23% -5,088.30% -1,896.89% 0.00% 0.00%
Pre Tax Income Margin		 -1,883.27% -8,110.00% -1,255.05% -2,727.93% -377.61% -2,221.39% -6,179.33% -2,409.97% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About MicroVision's Financials

When does MicroVision's financial year end?

According to the most recent income statement we have on file, MicroVision's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has MicroVision's net income changed over the last 2 years?

MicroVision's net income appears to be on an upward trend, with a most recent value of -$96.92 million in 2024, rising from -$53.09 million in 2022. The previous period was -$82.84 million in 2023. See where experts think MicroVision is headed by visiting MicroVision's forecast page.

What is MicroVision's operating income?
MicroVision's total operating income in 2024 was -$85.52 million, based on the following breakdown:
  • Total Gross Profit: -$2.83 million
  • Total Operating Expenses: $82.69 million
How has MicroVision revenue changed over the last 2 years?

Over the last 2 years, MicroVision's total revenue changed from $664 thousand in 2022 to $4.70 million in 2024, a change of 607.2%.

How much debt does MicroVision have?

MicroVision's total liabilities were at $72.39 million at the end of 2024, a 114.0% increase from 2023, and a 186.6% increase since 2022.

How much cash does MicroVision have?

In the past 2 years, MicroVision's cash and equivalents has ranged from $20.54 million in 2022 to $54.49 million in 2024, and is currently $54.49 million as of their latest financial filing in 2024.

How has MicroVision's book value per share changed over the last 2 years?

Over the last 2 years, MicroVision's book value per share changed from 0.54 in 2022 to 0.22 in 2024, a change of -58.8%.


Related Companies

This page (NASDAQ:MVIS) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...
Augusta Precious Metals | Sponsored